Trial Profile
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder: PRopiverine Study on Overactive Bladder Including Urgency Data (PROUD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2009
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Overactive bladder; Urge incontinence
- Focus Therapeutic Use
- Acronyms PROUD
- 01 Dec 2009 Primary endpoint 'Frequency of urgency episodes' has been met.
- 27 May 2009 New trial record